首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Identification, Isolation and Characterization of Process Related Impurity in Isosulfanblue
【24h】

Identification, Isolation and Characterization of Process Related Impurity in Isosulfanblue

机译:异硫丹蓝中与工艺有关的杂质的鉴定,分离和表征

获取原文
           

摘要

A new unknown impurity of isosulfanblue formed during the synthesis of isosulfanblue, and the level of the impurity was found at below 0.10%. This impurity was identified by Liquid Chromatography-Mass Spectrometry (LC-MS) and characterized by Proton Nuclear Magnetic Resonance (1H-NMR), Carbon-13 Nuclear Magnetic Resonance (13C-NMR), MS and Fourier-Transform Infrared Spectroscopy (FTIR). Based on the spectral data, the impurity was named as, N-4-[bis[4-(diethyl amino)phenyl] hydroxymethyl]-benzene-2,5-disulphonic acid. This impurity was isolated by preparative High-performance Liquid Chromatography (HPLC) and co-injected into HPLC to confirm the retention time. Isolation, structural elucidation of the impurity and its possible mechanism of formation has been discussed. To the best our knowledge, the formation, identification, isolation, characterization of the observed new impurity was not mentioned in the literature till date.
机译:在异硫丹蓝的合成过程中形成了新的未知的异硫丹蓝杂质,其杂质含量低于0.10%。通过液相色谱-质谱法(LC-MS)鉴定该杂质,并通过质子核磁共振(1H-NMR),碳13核磁共振(13C-NMR),质谱和傅立叶变换红外光谱(FTIR)对其进行表征。 。根据光谱数据,将该杂质命名为N-4- [双[4-(二乙基氨基)苯基]羟甲基]苯-2,5-二磺酸。通过制备型高效液相色谱(HPLC)分离该杂质,并共注入HPLC以确认保留时间。讨论了杂质的分离,结构解析及其可能的形成机理。据我们所知,迄今为止,文献中尚未提及观察到的新杂质的形成,鉴定,分离,表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号